Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-22
2000-08-15
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540145, 514183, A61K 3140, C07D48722
Patent
active
061037516
ABSTRACT:
A carotene conjugate of the formula: ##STR1## where R.sup.1 is hydrogen or methyl; R.sup.2 is: ##STR2## R.sup.3, R.sup.4 and R.sup.5 are independently, hydrogen, methyl or ethyl; R.sup.6 and R.sup.7 are independently --R.sup.13, --OR , --C(R.sup.6)(O), --C(R.sup.16).sub.2 OR.sup.13, --CH.dbd.CHR.sup.13, or --(CH.sub.2)R.sup.14 ; R.sup.8 is --R.sup.13, --OR.sup.13, --C(R.sup.16)(O), --C(R.sup.16).sub.2 OR.sup.13, --CH.dbd.CHR.sup.13, or --(CH.sub.2)R.sup.14 or taken with R.sup.10 is .dbd.O; R.sup.9 is --R.sup.13, --OR.sup.13, --C(R.sup.16)(O), --C(R.sup.16).sub.2 OR.sup.13, --CH.dbd.CHR.sup.13, or --(CH.sub.2)R.sup.14 or taken with R.sup.10 is a chemical bond; R.sup.10 is --R.sup.13, --OR.sup.13, --C(R.sup.16)(O) , --C(R.sup.16).sub.2 OR.sup.13, --CH.dbd.CHR.sup.13, or --(CH.sub.2)R.sup.14 or taken together with R.sup.9 is a chemical bond or taken with R.sup.8 is .dbd.O; R.sup.11 is R.sup.13, or --OR.sup.13 ; R.sup.12 is --C(R.sup.13).sub.2 C(Y)--, --C(O)O(O)C--, --C(NR.sup.13)O(O)C--, or --C(O)N(R.sup.15)--C(O)--; R.sup.13 is, independently at each occurrence, hydrogen or lower alkyl of from 1 through about 10 carbon atoms; R.sup.14 is an amino acid residue, R.sup.15 is --R.sup.13, --R.sup.14, or --C(O)NHR.sup.13 ; R.sup.16 is, independently at each occurrence, hydrogen or lower alkyl of 1 to about 4 carbon atoms and Y is .dbd.O, .dbd.S, or 2H--.
REFERENCES:
patent: 4649151 (1987-03-01), Dougherty et al.
patent: 4866168 (1989-09-01), Dougherty et al.
patent: 4889129 (1989-12-01), Dougherty et al.
patent: 4932934 (1990-06-01), Dougherty et al.
patent: 4968715 (1990-11-01), Dougherty et al.
patent: 5002962 (1991-03-01), Pandey et al.
patent: 5015463 (1991-05-01), Dougherty et al.
patent: 5028621 (1991-07-01), Dougherty et al.
patent: 5145863 (1992-09-01), Dougherty et al.
patent: 5198460 (1993-03-01), Pandey et al.
patent: 5225433 (1993-07-01), Dougherty et al.
patent: 5238940 (1993-08-01), Liu et al.
patent: 5286474 (1994-02-01), Gust, Jr. et al.
patent: 5314905 (1994-05-01), Pandey et al.
patent: 5459159 (1995-10-01), Pandey et al.
patent: 5498710 (1996-03-01), Pandey et al.
patent: 5591847 (1997-01-01), Pandey et al.
patent: 5773609 (1998-06-01), Robinson et al.
Beems, E. et al., Photosensitizing Properties Of Bacteriochlorophyllin .alpha. And Bacteriochlorin .alpha. , Two Derivatives Of Bacteriochlorophyll .alpha., Photochemistry and Photobiology, vol. 46, No. 5, pp. 639-643, 1987.
Dougherty T. et al., Photoradiation Therapy. II. Cure Of Animal Tumors With Hematoporphyrin And Light, Journal of the National Cancer Institute, vol. 55, No. 1, pp. 115-119, 1975.
Dougherty, T. et al., Photoradiation Therapy For The Treatment Of Malignant Tumors, Cancer Research, vol. 38, pp. 2628-2635, 1978.
Evensen, J. et al., Photodynamic Therapy Of C3H Mouse Mammary Carcinoma With Haematoporphyrin Di-Ethers As Sensitizers, Br. J. Cancer, 55, pp. 483-486, 1987.
Gomer, C. et al., Determination of [.sup.3 H]-And [.sup.14 C]Hematoporphyrin Derivative Distribution In Malignant and Normal Tissue, Cancer Research 39, pp. 146-151, 1979.
Henderson, B. et al., An In Vivo Quantitative Structure-Activity Relationship For A Congeneric Series Of Pyropheophorbide Derivatives As Photosensitizers For Photodynamic Therapy.sup.1, Cancer Research 57, pp. 4000-4007, 1997.
Hoober, J. et al., Photodynamic Sensitizers From Chlorophyll: Purpurin-18 And Chlorin .rho..sub.6, Photochemistry and Photobiology, vol. 48, No. 5, pp. 579-582, 1988.
Lee S. et al., Use Of The Chlorophyll Derivative, Purpurin-18, For Syntheses of Sensitizers For Use In Photodynamic Therapy, J. Chem. Soc. Perkin Trans. I, pp. 2369-2377, 1993.
Pandey R. et al., Fast Atom Bombardment Mass Spectral Analyses Of Photofrin II.RTM. And Its Synthetic Analogs, Biomedical and Enviromental Mass Spectrometry, vol. 19, pp. 405-414, 1990.
Pandey, R. et al., Chemistry Of Photofrin II And Some New Photosensitizers, SPIE vol. 1065 Photodynamic Therapy: Mechanisms, pp. 164-174, 1989.
Pandey, R. et al., Structure/Activity Relationships Among Photosensitizers Related To Pheophorbides And Bacteriopheophorbides, Bioorganic & Medicinal Chemistry Letters, vol. 2, No. 5, pp. 491-496, 1992.
Pandey, R. et al., Substituent Effects In Tetrapyrrole Subunit Reactivity And Pinacol-Pinacolone Rearrangements: Vic-Dihydroxychlorins And Vic-Dihydroxybacteriochlorins, Tetrahedron Letters, vol. 22, No. 51, pp. 7815-7818, 1992.
Pandey, R. et al., Alkyl Ether Analogs Of Chlorophyll-a Derivatives: Part 1. Synthesis, Photophysical Properties And Photodynamic Efficacy, Photochemistry and Photobiology, 64(1), pp. 194-204, 1996.
Pandey, R. et al., Evaluation Of New Benzoporphyrin Derivatives With Enhanced PDT Efficacy, Photochemistry and Photobiology, vol. 62, No. 4, pp. 764-768, 1995.
Pandey, R. et al., Synthesis Of New Bacteriochlorins And Their Antitumor Activity, Bioorg. and Med. Chem. Letters, 1992.
Weishaupt, K. et al., Identification Of Singlet Oxygen As The Cytotoxic Agent In Photo-Inactivation Of A Murine Tumor, Cancer Research 36, pp. 2326-2329, 1976.
Dougherty Thomas J.
Pandey Ravindra K.
Potter William R.
Dunn Michael L.
Health Research , Inc.
Shah Mukund J.
Sripada Pavanaram K
LandOfFree
Carotene analogs of porphyrins, chlorins and bacteriochlorins as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carotene analogs of porphyrins, chlorins and bacteriochlorins as, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carotene analogs of porphyrins, chlorins and bacteriochlorins as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2007340